MRI Atrophy Predicts Early-Onset Alzheimer's Progression
Analysis based on 11 articles · First reported Aug 26, 2026 · Last updated Aug 29, 2026
The study may boost interest in MRI-based biomarkers for Alzheimer's prognosis, potentially benefiting medical imaging and diagnostic companies. However, as a research finding, its immediate market impact is limited, with no direct effect on publicly traded companies.
Researchers at Mass General Brigham Neuroscience Institute, led by Alexandra Touroutoglou and Mark Eldaief, published a study in Neurology showing that a pattern of brain atrophy visible on MRI can predict how quickly patients with early-onset Alzheimer's disease progress from mild cognitive impairment to dementia. Analyzing data from 130 patients and 97 controls from the LEADS study, they found that greater baseline atrophy in memory-related brain regions was associated with faster progression, with each standard deviation increase in atrophy raising the risk of progression by 24%. The MRI measure improved prediction models beyond clinical severity alone. The findings could help patients and families plan for care, but the tool requires validation in diverse populations and is not yet ready for routine clinical use.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard